Cortigent Showcases Orion Brain Implant Clinical Progress
EMERYVILLE, Calif., January 22, 2026 — Vivani Medical announced that its wholly owned subsidiary Cortigent will present advanced clinical...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
EMERYVILLE, Calif., January 22, 2026 — Vivani Medical announced that its wholly owned subsidiary Cortigent will present advanced clinical...
SAN JOSÉ, Costa Rica, Dec. 29, 2025 — Establishment Labs has submitted a regulatory application to the U.S. Food...
